These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8353168)

  • 21. Dopamine uptake by platelets from subjects with schizophrenia: a correlation with the delusional state of the patient.
    Dean B; Kulkarni J; Copolov DL; Shrikanthan P; Malone V; Hill C
    Psychiatry Res; 1992 Jan; 41(1):17-24. PubMed ID: 1561286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radio receptor assay of serum neuroleptic levels in psychiatric patients.
    Krska J; Sampath G; Shah A; Soni SD
    Br J Psychiatry; 1986 Feb; 148():187-93. PubMed ID: 2870755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients.
    Coppens HJ; Slooff CJ; Paans AM; Wiegman T; Vaalburg W; Korf J
    Biol Psychiatry; 1991 Apr; 29(7):629-34. PubMed ID: 1675892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems.
    Keks NA; Copolov DL; Kulkarni J; Mackie B; Singh BS; McGorry P; Rubin RT; Hassett A; McLaughlin M; van Riel R
    Biol Psychiatry; 1990 Jun; 27(11):1203-15. PubMed ID: 2354227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Association between uptake to lymphocytes from schizophrenic patients and therapeutic efficacy].
    Shimogawa S; Kaku H; Yoshimoto S; Nakane Y
    Yakubutsu Seishin Kodo; 1986 Jun; 6(2):239-46. PubMed ID: 2877529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of 3H-spiperone to human lymphocytes: a biological marker in schizophrenia?
    Bondy B; Ackenheil M; Elbers R; Fröhler M
    Psychiatry Res; 1985 May; 15(1):41-8. PubMed ID: 2409568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clozapine concentrations and clinical response in schizophrenic patients.
    Jeffries JJ
    Am J Psychiatry; 1991 Oct; 148(10):1406-7. PubMed ID: 1772490
    [No Abstract]   [Full Text] [Related]  

  • 29. Binding of 3H-spiperone to human peripheral lymphocytes: absence of stereospecific high-affinity binding.
    Feenstra A; Coggiano MA; Wyatt RJ
    Psychiatry Res; 1989 Dec; 30(3):259-64. PubMed ID: 2482515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral-type benzodiazepine receptors in diagnostic subtypes of schizophrenic patients.
    Wodarz N; Rothenhöfer C; Fischer R; Stöber G; Kiehl B; Jungkunz G; Riederer P; Klein HE
    Psychiatry Res; 1998 Dec; 81(3):363-9. PubMed ID: 9925187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine concentrations and clinical response in schizophrenic patients.
    Owen JA; Delva NJ; Lawson JS
    Am J Psychiatry; 1992 Aug; 149(8):1120-1. PubMed ID: 1636820
    [No Abstract]   [Full Text] [Related]  

  • 35. [The binding of 3H-spiperone to lymphocytes in patients with schizophrenia and first-degree relatives: in search of a genetic marker].
    Heinze G; King GB; Huerto L; Ortega H; Cortés J; Ariza JR
    Gac Med Mex; 1994; 130(4):241-5. PubMed ID: 8964331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.
    Martinot JL; Peron-Magnan P; Huret JD; Mazoyer B; Baron JC; Boulenger JP; Loc'h C; Maziere B; Caillard V; Loo H
    Am J Psychiatry; 1990 Jan; 147(1):44-50. PubMed ID: 2293788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-endorphin, vasoactive intestinal peptide and cholecystokinin in peripheral blood mononuclear cells from healthy subjects and from drug-free and haloperidol-treated schizophrenic patients.
    Panza G; Monzani E; Sacerdote P; Penati G; Panerai AE
    Acta Psychiatr Scand; 1992 Mar; 85(3):207-10. PubMed ID: 1561892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [3H]spiroperidol binding on lymphocytes: changes in two different groups of schizophrenic patients and effect of neuroleptic treatment.
    Le Fur G; Zarifian E; Phan T; Cuche H; Flamier A; Bouchami F; Burgevin MC; Loo H; Gérard A; Uzan A
    Life Sci; 1983 Jan; 32(3):249-55. PubMed ID: 6130459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.
    Piscitelli SC; Frazier JA; McKenna K; Albus KE; Grothe DR; Gordon CT; Rapoport JL
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():94-7. PubMed ID: 7961584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of response to haloperidol dose reduction by Span of Apprehension measures for treatment-refractory schizophrenic patients.
    Green MF; Mintz J; Bowen L; Marshall BD; Kuehnel TG; Hayden JL; Liberman RP
    Am J Psychiatry; 1993 Sep; 150(9):1415-6. PubMed ID: 8352355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.